Saturday, May 23, 2026
ADVT 
International

UK opens second ballot for Young Professional visa scheme for Indians

Darpan News Desk IANS, 25 Jul, 2023 11:42 AM
  • UK opens second ballot for Young Professional visa scheme for Indians

London, July 25 (IANS) The UK government has announced the opening of the second ballot of the Young Professional Scheme for Indian citizens between 18 to 30 years of age.

The ballot, which opened on Monday, will close at 1.30 p.m. on Thursday, the British High Commission announced in a tweet.

The scheme, formally launched this year, allows Indian citizens with a graduate or postgraduate qualification to live and work in the UK for up to two years.

It allows the candidate to enter the UK at any time while their visa is valid, and leave and come back at any time during their stay. T

here are 3,000 places available for the India Young Professionals Scheme visa in 2023.

While most places were given in the first ballot which opened in February, the remaining places will be given in the July ballot.

Successful candidates in the ballot need to apply for their visa by the deadline given in a subsequent invitation to apply, which is usually within a month's period.

Also, they must travel to the UK within six months of applying for their visa.

The application fee charges have been set at 259 pounds and additional costs involved is a 940-pound healthcare surcharge and proof that the applicant has 2,530 pounds in personal savings.

To be eligible for the Young Professionals Scheme visa one must be an Indian national or citizen between 18 and 30 years old and have 2,530 pounds in savings to support themselves in the UK.

Also applicants should not have children under the age of 18 living with them or who they are financially responsible for.

MORE International ARTICLES

UK PM shoots down easing of immigration rules for Indians

UK PM shoots down easing of immigration rules for Indians
British Prime Minister Boris Johnson has shot down speculation that the UK will ease immigration rules for India as part of a Free Trade Agreement (FTA). Negotiations on an Indo-British FTA are scheduled to begin this month.

UK PM shoots down easing of immigration rules for Indians

Omicron not mild, hospitalising and killing people: WHO chief

Omicron not mild, hospitalising and killing people: WHO chief
While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as 'mild' as just like previous variants, Omicron is hospitalising people and it is killing people, WHO Director-General Dr Tedros Adhanom Ghebreyesus said on Thursday.

Omicron not mild, hospitalising and killing people: WHO chief

Biden: 'The way forward is to recognize the truth'

Biden: 'The way forward is to recognize the truth'
The president of the United States called out predecessor Donald Trump not by name but by reputation Thursday, marking one year since the Capitol Hill riots with a remarkably simple exhortation to his fellow Americans: to tell and spread and embrace the truth about the 2020 election.

Biden: 'The way forward is to recognize the truth'

Jan. 6 Capitol riot divides U.S.

Jan. 6 Capitol riot divides U.S.
Thursday marks one year since frenzied supporters of Donald Trump, spurred on by the outgoing president's bogus claims of a stolen election, laid siege to the U.S. Capitol in what's now widely seen as an organized effort to prevent Joe Biden from taking over as commander-in-chief.

Jan. 6 Capitol riot divides U.S.

Girl, 10, bound for Canada killed at Taliban stop

Girl, 10, bound for Canada killed at Taliban stop
Eleanor Taylor of the group Aman Lara, an organization that helps Afghans get out of the country, said the little girl named Nafiza was shot and killed while the family was travelling back from a wedding late in the evening of Dec. 10.

Girl, 10, bound for Canada killed at Taliban stop

Pfizer confirms COVID pill's results, potency versus omicron

Pfizer confirms COVID pill's results, potency versus omicron
The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.

Pfizer confirms COVID pill's results, potency versus omicron